TRANSFEMORAL TRICUSPID VALVE-IN-VALVE AND VALVE-IN-RING IMPLANTATION USING THE EDWARDS SAPIEN XT VALVE: ONE-YEAR FOLLOW-UP

Case DetailsA 26 year old gentleman who is a known case of chronic rheumatic heart disease, presented with exertional breathlessness of 1 year duration. He underwent percutaneous balloon mitral valvotomy in 2004 for severe mitral stenosis. ECG showed atrial fibrillation with controlled ventricular rates. 2D Echocardiography showed severe mitral restenosis (MVA=0.8 cm2; MVG =18/12, Panel A), Organic tricuspid valve disease with severe tricuspid stenosis (TVG=13/8, Panel B) with mild tricuspid regurgitation. Balloon mitral and tricuspid valvotomy was done sequentially in this patient with Acura 28 balloon, inflated to 28mm across mitral valve and 18mm across tricuspid valve with wire in LV and RV apex respectively (Panel C and D). There was significant drop in the trans-Valvular gradients (Panel E and F). Procedure was uneventful. The post procedure course was unremarkable and the patient is doing well at one year follow up.

Download Full-text

Transcatheter Tricuspid Valve-in-Valve Replacement with an Edwards Sapien 3 Valve

Texas Heart Institute Journal ◽

10.14503/thij-15-5639 ◽

2017 ◽

Vol 44 (3) ◽

pp. 209-213 ◽

Cited By ~ 4

Author(s):

Pranav Loyalka ◽

Angelo Nascimbene ◽

Benjamin Metz ◽

Igor D. Gregoric ◽

Ajay Sundara Raman ◽

...

Keyword(s):

Valve Replacement ◽

Tricuspid Valve ◽

Case Reports ◽

Case Series ◽

Tricuspid Valve Replacement ◽

Valvular Stenosis ◽

Edwards Sapien ◽

Transcatheter Implantation ◽

Valve In Valve ◽

Sapien 3

A few case reports and case series have documented the outcomes in patients with tricuspid bioprosthetic valvular degeneration who underwent transcatheter implantation of the Medtronic Melody and the Edwards Sapien XT and Sapien 3 valves. In this report, we describe the case of a 49-year-old woman with severe bioprosthetic tricuspid valvular stenosis and multiple comorbidities who underwent transcatheter tricuspid valve replacement with a Sapien 3 valve.

Download Full-text

Transvenous Transcatheter Valve-in-Valve Implantation after Bioprosthetic Tricuspid Valve Failure

Texas Heart Institute Journal ◽

10.14503/thij-14-4302 ◽

2014 ◽

Vol 41 (5) ◽

pp. 507-510 ◽

Cited By ~ 9

Author(s):

Ali Mortazavi ◽

Ross M. Reul ◽

Leon Cannizzaro ◽

Kathryn G. Dougherty

Keyword(s):

Tricuspid Valve ◽

Shortness Of Breath ◽

Tricuspid Valve Replacement ◽

Thoracic Surgical Procedures ◽

Edwards Sapien ◽

Cardiology Clinic ◽

History Of ◽

Valve In Valve ◽

Transcatheter Valve ◽

Valve Implantation

We describe the case of a 38-year-old man with a history of metastatic testicular cancer who had undergone multiple thoracic surgical procedures, including tricuspid valve replacement with a bioprosthetic valve as a result of tricuspid involvement of his malignancy. He presented at our outpatient cardiology clinic with worsening fatigue, shortness of breath, and peripheral edema, investigation of which revealed severe tricuspid bioprosthesis stenosis with central regurgitation. Because of the patient's medical history, he was considered to be a high-risk surgical candidate. Therefore, transcatheter tricuspid valve-in-valve implantation of a 26-mm Edwards Sapien® valve was attempted through a transjugular approach. The procedure restored tricuspid valvar competence and substantially improved the patient's symptoms. We discuss the technical aspects of this case and briefly review the usefulness of the valve-in-valve technique in the tricuspid position.

Download Full-text

Transcatheter tricuspid valve-in-valve replacement: one-year results

Heart and Vessels ◽

10.1007/s00380-016-0921-z ◽

2016 ◽

Vol 32 (4) ◽

pp. 495-500

Author(s):

João Mesquita ◽

Rui Campante Teles ◽

José Pedro Neves ◽

João Abecasis ◽

Pedro Carmo ◽

...

Keyword(s):

Valve Replacement ◽

Tricuspid Valve ◽

Valve In Valve ◽

One Year

Download Full-text

Long term outcomes of patients with aortic structural valve deterioration treated with transcatheter valve in valve implantation

European Heart Journal ◽

10.1093/eurheartj/ehab724.1627 ◽

2021 ◽

Vol 42 (Supplement_1) ◽

Author(s):

N Schamroth Pravda ◽

P Codner ◽

H Vaknin Assa ◽

G Vitberg ◽

L Perl ◽

...

Keyword(s):

Aortic Valve ◽

Aortic Regurgitation ◽

Functional Class ◽

Nyha Functional Class ◽

Long Term Follow Up ◽

Valve In Valve ◽

One Year ◽

Valve Implantation

Abstract Introduction The Valve-in-Valve (ViV) technique is an established alternative for the treatment of structural bioprosthetic valve deterioration (SVD). Data describing the long term follow up of patients treated with this approach is scarce. We report on our long-term follow up outcomes of patients with SVD in the Aortic position treated with ViV. Methods Included were patients with symptomatic SVD in the aortic position valve who were treated by Valve in valve transcatheter aortic valve implantation (ViV-TAVI) during the years 20102019 in our center. Three main outcomes were examined during follow up: NYHA functional class, hemodynamic of the VIV-TAVI per echocardiography, and overall mortality. Results Our cohort consisted of 84 patients (mean age 78.8±8.9 years). The indications for aortic ViV were: SVD isolated aortic stenosis in 37.6%, SVD isolated aortic regurgitation in 42.2% and combined valve pathology in 20.0%. Self-expandable and balloon-expandable devices were used in 73 (85.9%) and 12 (14.1%), respectively. Average time of follow up was 3.74±2.4 years. 95% and 91% of patients were in NYHA functional class I/II at 1 and 5 year follow up respectively. At one year the mean trans-aortic valve pressure was 15.3±9.3 and rates of ≥ moderate aortic regurgitation were 3.7%. Survival was 91.4% (95% CI 85.6–97.7) at one year and 79.5% (95% CI 70.2–90.0) at 3 years. Conclusion ViV in the aortic position offers an effective and durable treatment option for patient with SVD, with low rates of all-cause mortality, excellent hemodynamic and improved functional capacity at 3 years follow up. FUNDunding Acknowledgement Type of funding sources: None. NYHA functional class over follow up

Download Full-text

Jailing of a Pacemaker Lead During Tricuspid Valve-in-Valve Implantation With an Edwards SAPIEN XT Transcatheter Heart Valve

Canadian Journal of Cardiology ◽

10.1016/j.cjca.2015.01.037 ◽

2015 ◽

Vol 31 (6) ◽

pp. 819.e9-819.e11 ◽

Cited By ~ 6

Author(s):

Jean-Michel Paradis ◽

Mathieu Bernier ◽

Christine Houde ◽

Éric Dumont ◽

Daniel Doyle ◽

...

Keyword(s):

Heart Valve ◽

Tricuspid Valve ◽

Pacemaker Lead ◽

Transcatheter Heart Valve ◽

Edwards Sapien ◽

Valve In Valve ◽

Valve Implantation

Download Full-text

Valve-in-Valve-in-Valve: Percutaneous Tricuspid Valve Rehabilitation for a Stenosed Percutaneous Implanted 26-mm Edwards SAPIEN Valve in a Young Man With Complex Congenital Heart Disease

Heart Lung and Circulation ◽

10.1016/j.hlc.2018.06.819 ◽

2018 ◽

Vol 27 ◽

pp. S406-S407

Author(s):

S. Nguyen ◽

S. Fogarty ◽

M. Nicolae ◽

P. Roberts

Keyword(s):

Congenital Heart Disease ◽

Heart Disease ◽

Tricuspid Valve ◽

Congenital Heart ◽

Complex Congenital Heart Disease ◽

Edwards Sapien ◽

Edwards Sapien Valve ◽

Valve In Valve

Download Full-text

The Use of Adenosine to Enable Safe Implantation of Transcatheter Tricuspid Valve

Case Reports in Cardiology ◽

10.1155/2017/2760580 ◽

2017 ◽

Vol 2017 ◽

pp. 1-3

Author(s):

Vicki Zeniou ◽

Shmuel Chen ◽

Mony Shuvy ◽

David Luria ◽

Chaim Lotan ◽

...

Keyword(s):

Heart Rate ◽

Cardiac Arrest ◽

Cardiac Output ◽

Tricuspid Valve ◽

Transcatheter Heart Valve ◽

Edwards Sapien ◽

Valve Position ◽

Rapid Pacing ◽

Valve In Valve ◽

Valve Implantation

High precision is necessary during percutaneous transcatheter heart valve implantation. The precision of the implantation has been established by increasing the heart rate (usually to 200 beats per minute) to the point of significantly reduced cardiac output and thus minimizing valve movement. Routinely, this tachycardia is induced by rapid pacing. Here we report a case of failure to pace during valve-in-valve (VIV) Edwards Sapien XT implantation in the tricuspid valve position. Transient cardiac arrest was induced by intravenous adenosine injection enabling accurate valve implantation.

Download Full-text